Zimmer Biomet sales rise 3.2% in Q1

Spinal Tech

Zimmer Biomet saw $1.89 billion in net sales in the first quarter of 2024, according to its 2024 financial report, published May 2. 

That is a 3.2% increase from the year prior, and a 4.4% increase on a constant currency basis. Additionally, net earnings for the first quarter reached $172.4 million. 

Zimmer Biomet saw a 3.4% increase in its total global knee sales in the first quarter, along with a 0.3% decrease in total hip sales. 

In the first quarter, the company earned FDA clearance for its Rosa shoulder system and its femoral hip stem and announced partnerships with three top pickleball organizations in the U.S. 

The company is now projecting a 4.5% to 5.5% increase in total revenue in 2024. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers